Claire Sherman

VP, Clinical Biometrics at Alkahest

Claire has more than 30 years of experience in mathematical, statistical, and computational roles in academe, federal and state government research and regulatory environments, and biotechnology and pharmaceutical industries. Prior to Alkahest, Claire has been instrumental in building Biostatistics and Biometrics teams in mid and small/start-up companies. She has held positions of increasing responsibility at Merck, Genentech, Cerus, Puma Biotechnology, Theravance Biopharma, Global Blood Therapeutics, and most recently CytomX Therapeutics. Claire received her Ph.D. in Statistics from the University of Waterloo, Ontario, Canada. She is a life-long learner of statistical and programming techniques with the objective of discovering useful information, informing conclusions, and supporting decision-making from the data she manages with her teams.


Org chart


Teams


Offices

This person is not in any offices


Alkahest

Alkahest is developing therapies derived from blood to treat neurological diseases, with an emphasis on the age-related cognitive decline - key medical challenges of our generation.


Industries

Employees

51-200

Links